ChemoCentryx, Inc.
CCXI · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $50 | $32 | $39 | $28 |
| Short-Term Investments | $215 | $404 | $134 | $149 |
| Receivables | $0 | $0 | $0 | $2 |
| Inventory | $1 | $0 | $0 | $0 |
| Other Curr. Assets | $3 | $5 | $1 | $2 |
| Total Curr. Assets | $269 | $442 | $174 | $181 |
| Property Plant & Equip (Net) | $57 | $52 | $4 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $98 | $24 | $29 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $1 | $1 | $0 |
| Total NC Assets | $156 | $77 | $35 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $426 | $519 | $209 | $183 |
| Liabilities | – | – | – | – |
| Payables | $7 | $13 | $2 | $1 |
| Short-Term Debt | $19 | $7 | $2 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $11 | $13 | $38 | $50 |
| Other Curr. Liab. | $26 | $19 | $18 | $13 |
| Total Curr. Liab. | $63 | $52 | $59 | $64 |
| LT Debt | $5 | $18 | $20 | $20 |
| Deferred Rev, NC | $25 | $24 | $63 | $84 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $47 | $40 | $1 | $0 |
| Total NC Liab. | $77 | $82 | $84 | $104 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $140 | $133 | $143 | $169 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$617 | -$485 | -$430 | -$374 |
| AOCI | -$0 | $0 | $0 | -$0 |
| Other Equity | $904 | $871 | $496 | $389 |
| Total Equity | $286 | $386 | $66 | $15 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $426 | $519 | $209 | $183 |
| Net Debt | -$26 | -$7 | -$18 | -$8 |